Company Number: 13007073

Analysis Date: 2025-07-19 12:03 UTC

1. Credit Opinion: DECLINE
   AKEHARD CARE LIMITED exhibits extremely weak financial strength with zero net assets and no equity buffer as of the latest accounts. Current liabilities consistently match current assets, resulting in negligible working capital. There is no evidence of cash reserves or operational scale, with no employees reported. The minimal financial activity and lack of tangible assets raise serious concerns about the company's ability to service any debt or credit facility. The business shows no growth or meaningful financial trajectory since incorporation in 2020. Without positive cash flow or capital, the risk of default is high. Therefore, credit approval is not recommended.

2. Financial Strength:
   The company’s balance sheet is minimalistic and effectively at break-even with net assets of £0 for the year ending 30 November 2024. There are no fixed assets, and current assets consist solely of very small amounts of cash or receivables (£294 in 2024 vs £3,068 in 2023). Current liabilities exactly offset current assets, indicating zero working capital. Shareholders’ funds are non-existent, and no reserves or retained earnings are reported. The micro-entity status and lack of employees suggest a non-operational or dormant business status financially.

3. Cash Flow Assessment:
   Current assets have dramatically declined from £3,068 in 2023 to £294 in 2024, indicating a significant reduction in liquidity. The matching current liabilities imply no net cash available to meet short-term obligations beyond immediate liabilities. The absence of operational employees and any fixed assets further points to very limited business activity and cash generating capability. The company likely depends on external funding or shareholder support to continue.

4. Monitoring Points:

• Monitor future filings for any increase in tangible assets or working capital improvements.
• Watch for changes in current liabilities structure or any overdue payments that could signal distress.
• Review director reports or filings for any strategic changes or capital injections.
• Track any appointment of new directors or PSCs that could indicate a restructuring or infusion of capital.
• Monitor for any late filing or compliance issues that could further degrade credit standing.